Catalyst Wire Dossier Catalyst Wire Dossier

GM-CT-01

GM-CT-01 · Galectin Therapeutics Inc.
Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for GM-CT-01, covering 2012-03-06 to 2017-08-01. Get the full timeline:

Most recent: Clinical Trial Update: Study to Test the Benefit and Safety of GM-CT-01 in Combination With 5-FU to Treat Bile Duct and Gall Bladder Cancer [Phase 2]

See pricing